DVAX
Dynavax Technologies Corporation
Company Overview
| Mkt Cap | $1.23B | Price | $10.26 |
| Volume | 1.76M | Change | -1.35% |
| P/E Ratio | 44.9 | Open | $10.30 |
| Revenue | $282.3M | Prev Close | $10.40 |
| Net Income | $27.3M | 52W Range | $9.20 - $14.63 |
| Div Yield | N/A | Target | $22.67 |
| Overall | 51 | Value | 40 |
| Quality | -- | Technical | 63 |
No chart data available
Stock Overview
Updated DailyDynavax Technologies Corporation (DVAX) is a leading Healthcare company in the Biotechnology industry, currently trading at $10.26 with a market capitalization of $1.23 billion. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows DVAX with a volume of 1.76 million shares. The stock opened down 0.96% from yesterday's close of $10.40. Current analyst estimates project earnings of $-0.06 per share for this year, with next year targeting $0.64.
DVAX demonstrates positive technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including IDRA, AGEN, BIIB, MRK, GILD.
Key investment considerations for DVAX include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 121.0%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 2, 2025 at 04:54 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DVAX | $10.26 | -1.3% | 1.76M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Dynavax Technologies Corporation Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW